Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

A legfontosabb adatok

Ki végzi
Anna Evans Phillips
Hol
Baltimore és Pittsburgh (Egyesült Államok)Mind a 2 helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
500 fő, tervezett
Kezdés
2017. okt. 24.
Várható befejezés
2031. jún. 30.
A vizsgálat típusa
Beavatkozással járó, 4 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Quantitative Sensory Test 1
  • Quantitative Sensory Test 2
  • Quantitative Sensory Test 3
A regiszteradat frissítve
2026. szeptember 11.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 8 feltétel megnézéseKevesebb

Ki vehet részt

  • Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia; Subjects are 18 years or older in age; Subjects must be able to read and understand the study information; Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subject is willing and able to comply with the scheduled visits, questionnaires, treatment plan, and other study procedures
  • Suspected CPs Inclusion Criteria; Subjects are 18 years or older in age; Subjects with a) Indeterminate CP (Cambridge 1 or 2 on CT scan or MRI/MRCP) who have abdominal pain without prior history of AP, or b) those with acute (AP) or recurrent acute pancreatitis (RAP) who have recovered from their attack(s) of AP, whose imaging studies are either normal or show changes consistent with Cambridge classification of 1 or 2, and they have ongoing abdominal pain. Both diabetic and non-diabetic subjects will be allowed to enter the study; Subjects must be able to read and understand the study information; Subjects must suffer from abdominal pain suspected to be pancreatic origin with an intensity above 3 on the visual analogue scale (VAS, where 0=no pain and 10= intolerable pain), and meet the criteria for chronic pain (pain ≥ 3 days per week for at least 3 months); Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures
  • Definite Chronic Pancreatitis - Inclusion Criteria; Subjects are 18 years or older in age; Subjects will have a prior confirmed diagnosis of CP on CT scan or MRI/MRCP according to Cambridge Classification (grade 3 or 4). Both diabetic and non-diabetic subjects will be allowed to enter the study; Subjects must be able to read and understand the study information; Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures
  • Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Inclusion Criteria; Subjects are 18 years or older in age; Subjects have prior diagnosis of Type 1 or Type 2 Sphincter of Oddi Dysfunction (subjects with biliary pain accompanied by biochemical features of transient biliary tract obstruction including elevated transaminases, alkaline phosphatase, or conjugated bilirubin; may also be accompanied by biliary or pancreatic ductal dilation on imaging); Subjects must be able to read and understand the study information; Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures

Ki nem vehet részt

  • Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions that make them unable to distinguish the pain associated with CP from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas
  • Suspected CPs Exclusion Criteria; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions other than pancreatitis or SOD type 1 or 2 that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas
  • Definite Chronic Pancreatitis Exclusion Criteria; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions other than pancreatitis or SOD type 1 or 2 that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas
  • Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Exclusion Criteria; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions other than pancreatitis or SOD that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • Johns Hopkins Medical InstitutionsBaltimore, Egyesült ÁllamokContact: Mahya Faghih, M.D.Résztvevőt keres
  • University of Pittsburgh Medical CenterPittsburgh, Egyesült ÁllamokContact: Anna Evans-Phillips, MDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.

A vizsgálat 4 csoportja

  • Healthy ControlsMár használt kezelés, összehasonlításként

    Subjects with no pancreatic disease and no abdominal pain. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.

    Kezelés: Quantitative Sensory Test 1, Quantitative Sensory Test 2 és Quantitative Sensory Test 3

  • Suspected CPMár használt kezelés, összehasonlításként

    Suspected Chronic Pancreatitis patients. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.

    Kezelés: Quantitative Sensory Test 1, Quantitative Sensory Test 2 és Quantitative Sensory Test 3

  • Definite CPMár használt kezelés, összehasonlításként

    Definite Chronic Pancreatitis patients. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires. A subset of these patients who undergo endotherapy as per clinical recommendation from clinical provider independent of this study will be followed for 6 months after their clinical intervention for repeat Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3 and questionnaires.

    Kezelés: Quantitative Sensory Test 1, Quantitative Sensory Test 2 és Quantitative Sensory Test 3

  • Sphincter of Oddi Dysfunction or Functional DyspepsiaMár használt kezelés, összehasonlításként

    Patients with Sphincter of Oddi Dysfunction Type 1 or Type 2, or who have a prior diagnosis of Functional Dyspepsia. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.

    Kezelés: Quantitative Sensory Test 1, Quantitative Sensory Test 2 és Quantitative Sensory Test 3

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Publikációk
A regiszteradat frissítve
2026. szeptember 11.